Unsupervised survival prediction model from CT images of patients with COVID-19

Tomoki Uemura; Janne J. Näppi; Chinatsu Watari; Tohru Kamiya; Hiroyuki Yoshida

doi:10.1117/12.2581929

12 March 2021 Unsupervised survival prediction model from CT images of patients with COVID-19

Tomoki Uemura, Janne J. Näppi, Chinatsu Watari, Tohru Kamiya, Hiroyuki Yoshida

Proceedings Volume 11597, Medical Imaging 2021: Computer-Aided Diagnosis; 1159732 (2021) https://doi.org/10.1117/12.2581929
Event: SPIE Medical Imaging, 2021, Online Only

Conference Poster

Abstract

We developed an image-based unsupervised survival prediction model, called pix2surv, based on a conditional generative adversarial network (cGAN), and evaluated its performance based on chest CT images of patients with the coronavirus disease 2019 (COVID-19). The architecture of the pix2surv model includes a time generator that consists of an encoding convolutional network and a fully connected prediction network, and a discriminator network. The time generator is trained to generate survival-time images from chest CT images of each patient. The discriminator is a patch-based convolutional network that is trained to differentiate between “fake pairs” of a chest CT image and a generated survival-time image from “true pairs” of the chest CT image and the corresponding observed survival-time image of the patient. For evaluation, we retrospectively collected high-resolution chest CT images of COVID-19 patients. The survival predictions of the pix2surv model on these patients were compared with those of existing clinical prognostic biomarkers by use of a two-sided t-test with bootstrapping. Concordance index (C-index) and relative absolute error (RAE) were used as measures of the prediction performance. The bootstrap evaluation yielded C-index and RAE values of 80.4% and 15.6% for the pix2surv model, whereas those for the extent of the well-aerated lung parenchyma were 49.8% and 33.6%, and for a combination of blood tests of lactic dehydrogenase, lymphocyte, and C-reactive protein were 69.8% and 25.5%, respectively. The increase in survival prediction by the pix2surv model was statistically significant (p < 0.0001), indicating high effectiveness of the pix2surv model as a prognostic biomarker for the survival of patients with COVID-19.

Conference Presentation

Citation Download Citation

Tomoki Uemura, Janne J. Näppi, Chinatsu Watari, Tohru Kamiya, and Hiroyuki Yoshida "Unsupervised survival prediction model from CT images of patients with COVID-19", Proc. SPIE 11597, Medical Imaging 2021: Computer-Aided Diagnosis, 1159732 (12 March 2021); https://doi.org/10.1117/12.2581929

ACCESS THE FULL ARTICLE

INSTITUTIONAL
Select your institution to access the SPIE Digital Library.

SELECT YOUR INSTITUTION

PERSONAL
Sign in with your SPIE account to access your personal subscriptions or to use specific features such as save to my library, sign up for alerts, save searches, etc.

PERSONAL SIGN IN

No SPIE Account? Create one

PURCHASE THIS CONTENT

SUBSCRIBE TO DIGITAL LIBRARY

50 downloads per 1-year subscription

Members: $195

Non-members: $335 ADD TO CART

25 downloads per 1 - year subscription

Members: $145

Non-members: $250 ADD TO CART

PURCHASE SINGLE ARTICLE

Includes PDF, HTML & Video, when available